These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27698103)

  • 21. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
    Ringold S; Weiss PF; Beukelman T; DeWitt EM; Ilowite NT; Kimura Y; Laxer RM; Lovell DJ; Nigrovic PA; Robinson AB; Vehe RK;
    Arthritis Rheum; 2013 Oct; 65(10):2499-512. PubMed ID: 24092554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    Guzman J; Gómez-Ramírez O; Jurencak R; Shiff NJ; Berard RA; Duffy CM; Oen K; Petty RE; Benseler SM; Brant R; Tucker LB
    J Rheumatol; 2014 Nov; 41(11):2260-9. PubMed ID: 25225279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management.
    Jacobson JL; Pham JT
    J Pediatr Health Care; 2018; 32(5):515-528. PubMed ID: 30177013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis.
    Crayne CB; Beukelman T
    Pediatr Clin North Am; 2018 Aug; 65(4):657-674. PubMed ID: 30031492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mizoribine oral pulse therapy for a patient with polyarticular juvenile idiopathic arthritis.
    Hayashi A; Hanada T; Kohda T; Okada S; Kanzaki S; Kasagi T; Utsunomiya Y
    Pediatr Int; 2006 Dec; 48(6):638-40. PubMed ID: 17168989
    [No Abstract]   [Full Text] [Related]  

  • 28. [New drugs for treatment of juvenile idiopathic arthritis].
    Horneff G
    Z Rheumatol; 2019 Sep; 78(7):587-598. PubMed ID: 31098699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic drug access and juvenile idiopathic arthritis in Canada: improving collaboration between clinician experts and funders.
    Cohen E; Grill A; Coyle D
    J Rheumatol; 2013 Mar; 40(3):338. PubMed ID: 23457402
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel treatment options for juvenile idiopathic arthritis.
    Steigerwald KA; Ilowite NT
    Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.
    Taxter AJ; Wileyto EP; Behrens EM; Weiss PF
    J Rheumatol; 2015 Oct; 42(10):1914-21. PubMed ID: 26329337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current therapy of polyarticular forms of juvenile idiopathic arthritis].
    Hospach A; Rühlmann JM; Weller-Heinemann F
    Z Rheumatol; 2016 Apr; 75(3):284-91. PubMed ID: 27001055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
    Beukelman T; Patkar NM; Saag KG; Tolleson-Rinehart S; Cron RQ; DeWitt EM; Ilowite NT; Kimura Y; Laxer RM; Lovell DJ; Martini A; Rabinovich CE; Ruperto N
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):465-82. PubMed ID: 21452260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a treat-to-target approach in the management of juvenile idiopathic arthritis.
    Consolaro A; Negro G; Lanni S; Solari N; Martini A; Ravelli A
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S157-62. PubMed ID: 23072725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.
    Kumar S
    Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing regimen determination for juvenile idiopathic arthritis: a review of studies during drug development.
    Ji P; Chowdhury BA; Yim S; Sahajwalla CG
    J Pharm Sci; 2012 Aug; 101(8):2621-34. PubMed ID: 22653876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates in Juvenile Idiopathic Arthritis.
    McCurdy D; Parsa MF
    Adv Pediatr; 2021 Aug; 68():143-170. PubMed ID: 34243850
    [No Abstract]   [Full Text] [Related]  

  • 40. Recognition and treatment of arthritis in children.
    Rothschild BM
    Compr Ther; 1999; 25(6-7):347-59. PubMed ID: 10470519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.